[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100593903":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":41,"responsibleParty":59,"collaborators":25,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":25,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":70,"enrollmentInfo":71,"targetDuration":25,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":44,"whyStopped":25,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Shanghai Zhongshan Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Arm","ACTIVE_COMPARATOR","oral dihydroartemisinin (DHA) combined with topical minoxidil",[13],"Drug: Oral DHA + Topical minoxidil 5%",{"label":15,"type":6,"description":16,"interventionNames":17},"Control Arm","topical minoxidil alone",[18],"Drug: Topical Minoxidil 5%",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Oral DHA + Topical minoxidil 5%","DHA 20mg tid po plus daily topical minoxidil 5% for 180 days",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Topical Minoxidil 5%","Topical minoxidil 5% daily for 180 days",[15],[31],{"name":32,"affiliation":33,"role":34},"Jingjing JIANG, MD, PhD","Fudan University","PRINCIPAL_INVESTIGATOR",[36],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},"Lujuan GAO, MD, PhD","CONTACT","86-021-64041990","gao.lujuan@zs-hospital.sh.cn",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Zhongshan Hospital Fudan University","RECRUITING","Shanghai","Shanghai Municipality","200032","China","CN",{"type":51,"coordinates":52},"Point",[53,54],121.45806,31.22222,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":39,"phoneExt":25,"email":40},"Lujuan, MD, PhD",{"type":60,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100593903","early-phase-1-efficacy-of-dihydroartemisinin-for-treating-female-androgenetic-alopecia-100593903",false,"NCT07012486","Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia","A Pilot Study to Evaluate the Therapeutic Effect of Dihydroartemisinin on Female Androgenetic Alopecia","Inclusion Criteria:\n\n* Clinically diagnosed with androgenetic alopecia (AGA)\n* No pregnancy plans within the next 6 months\n\nExclusion Criteria:\n\n* Patients who received systemic medications for hair loss within the past 2 months\n* Use of topical medication for hair loss within the past 2 weeks\n* Pregnancy or lactation\n* Patients with known severe diseases of vital organs (e.g., heart, liver, kidney) or malignancies.","FEMALE","18 Years","40 Years",{"count":72,"type":73},30,"ESTIMATED","INTERVENTIONAL",[76],"EARLY_PHASE1","The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is:\n\n• Does DHA increase terminal hair follicles in the vertex area. Researchers will compare oral DHA plus topical minoxidil to topical minoxidil alone in female patients with AGA to see if DHA works to alleviate AGA.\n\nParticipants will:\n\n* Receive oral DHA every day plus topical minoxidil or use topical minoxidil alone for 6 months.\n* Visit the clinic once every month for checkups and tests.",[79],"Androgenetic Alopecia (AGA)",[81,82],"androgenetic alopecia","dihydroartemisinin","2025-06-09",{"date":85,"type":86},"2025-06-10","ACTUAL",{"date":88,"type":73},"2025-06",{"date":90,"type":73},"2026-12",{"name":5,"class":6},1]